Bristol Myers Squibb reported $2.68B in Cost of Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbott ABT:US $ 4933M 54M
Abbvie ABBV:US $ 4142M 121M
ALKERMES ALKS:US 58.36M 3.2M
Amgen AMGN:US $ 1510M 51M
Astrazeneca AZN:US 1.9B 375M
AstraZeneca AZN:LN 156386.94M 17145.23M
Biogen BIIB:US $ 484M 269.9M
Bristol Myers Squibb BMY:US $ 2677M 206M
Catalent CTLT:US $ 825M 25M
Coherus Biosciences CHRS:US $ 11.28M 1.91M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Endo International Ordinary Shares ENDP:US $ 263.79M 84.03M
Gilead Sciences GILD:US $ 1442M 18M
GlaxoSmithKline GSK:LN 213600M 55400M
Horizon Pharma HZNP:US $ 230.22M 15.15M
Intercept Pharmaceuticals ICPT:US $ 0.31M 0.45M
JAZZ PHA JAZZ:US $ 124.21M 8.92M
Johnson & Johnson JNJ:US $ 7919M 321M
Lannett LCI:US $ 66.33M 8.95M
Medtronic MDT:US $ 2467M 98M
Merk MRK:US $ 3698M 1636M
Novartis NOVN:VX SF 3749M 6M
Perrigo Ordinary Shares PRGO:US $ 749.6M 12.9M
Pfizer PFE:US $ 8671M 1339M
Phibro Animal Health PAHC:US $ 176.84M 8.85M
Prestige Brands PBH:US $ 116.94M 1.13M
Regeneron Pharmaceuticals REGN:US $ 297.1M 107.8M
Revance Therapeutics RVNC:US $ 9.52M 1.63M
Teva Pharmaceutical Industries TEVA:US $ 1958M 99M
United Therapeutics UTHR:US $ 29.7M 3.8M
Zoetis ZTS:US $ 620M 55M